Completed PHASE4 INTERVENTIONAL 2-arm NCT01379079

Aspirin in Reduction of Tension II Study (ASPIRETENSION)

Aspirin AM or PM in Reduction of Tension: a Randomized Cross-over Trial

Sponsor: Leiden University Medical Center

Conditions Cardiovascular Diseases Hypertension

Interventions Acetylsalicylic acid Acetylsalicylic acid lysinate

Updated 5 times since 2017 Last updated: May 12, 2014 Started: Apr 30, 2011 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cardiovascular Diseases and Hypertension and is currently completed. Leiden University Medical Center leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Leiden University Medical Center
Netherlands Heart Foundation

Data source: Leiden University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leiden, Netherlands